C-2GLFAmelia Technologies
DNA damage quantification, aging therapeutics
research tools
Loading
Loading section...0-100 chain-logic scale · 15 dimensions · scored on public evidence
←All companiesC-2GLF
C-2GLFC-2GLFDNA damage quantification, aging therapeutics
0-100 chain-logic scale · 15 dimensions · scored on public evidence
Amelia Technologies states that aging is meaningfully connected to the accumulation of DNA damage, that understanding how this damage affects health is important, and that measuring DNA damage in cells can help guide therapeutic insight for aging-related disorders.
SourceAmelia Technologies presents itself as a rapidly expanding biotechnology company founded in 2018, led by experienced scientific entrepreneurship, and states that its team is united by a desire to improve the natural world around them.
SourceAmelia Technologies presents itself as a biotechnology company driven by a desire to improve the natural world, emphasizing growth, scientific entrepreneurship, and a team united around that goal.
SourceAmelia Technologies states that aging involves the accumulation of DNA damage and that this damage affects human health. The company says it is focused on developing technologies to measure DNA damage in cells and use those measurements to inform therapies for aging-related disorders caused by that damage.
SourceAmelia Technologies presents itself as a biotechnology company operating between academia and industry, with a stated focus on understanding how human health is affected as DNA damage accumulates during aging. The snapshot indicates the company believes age-related DNA damage is an important mechanism for explaining changes in health over time.
Source